676PDHealth-related quality of life (HRQoL) impact of...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

676PDHealth-related quality of life (HRQoL) impact of pembrolizumab (pembro) versus best supportive care (BSC) in previously systemically treated patients (pts) with advanced hepatocellular carcinoma (HCC): KEYNOTE-240

Merle, P, Kulkarni, A S, Ryoo, B-Y, Cheng, A-L, Kudo, M, Bouattour, M, Lim, H Y, Breder, V, Edeline, J, Chao, Y, Ogasawara, S, Yau, T, Garrido, M, Chan, S, Daniele, B, Norquist, J, Chen, E, Siegel, A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.004
Date:
October, 2019
File:
PDF, 77 KB
2019
Conversion to is in progress
Conversion to is failed